• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553640
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Vomiting (2144); Embolism/Embolus (4438); Hematemesis (4478)
Event Date 01/26/2022
Event Type  Injury  
Event Description
It was reported to boston scientific corporation on (b)(6) 2022 that a hot axios stent was implanted transgastric to the pancreas to treat a pancreatic pseudocyst during a cystgastrostomy procedure performed on (b)(6) 2022.On (b)(6) 2022, during emergent follow- up, the patient presented with hematemesis.The patient had upper gastrointestinal bleeding and was sent to interventional radiology (ir).Angiography was performed and no active bleeding was noted; however, the left gastric artery and splenic artery were embolized.On (b)(6) 2022, bleeding was noted again.Endoscopic ultrasound (eus) guided coils and glue of the splenic varices were performed.The stent remains implanted and the physician is comfortable leaving the stent in place.The patient is being evaluated and will be going into surgery.In the physician's assessment the axios stent is related to the patient complications as the splenic varix error into axios stent.
 
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: patient code e1016 captures the reportable event of hematemesis.Patient code e0506 captures the reportable event of bleeding.Impact code f23 captures the reportable event of eus guided coils placement.Impact code f08 captures the reportable event of prolonged hospitalization.Impact code f19 captures the reportable event of planned surgery.Evaluation conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complainant indicated that the device remains implanted and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Block h11: blocks h6 (patient codes) and h10 have been corrected.
 
Event Description
It was reported to boston scientific corporation on february 01, 2022 that a hot axios stent was implanted transgastric to the pancreas to treat a pancreatic pseudocyst during a cystgastrostomy procedure performed on (b)(6) 2022.On (b)(6) 2022, during emergent follow- up, the patient presented with hematemesis.The patient had upper gastrointestinal bleeding and was sent to interventional radiology (ir).Angiography was performed and no active bleeding was noted; however, the left gastric artery and splenic artery were embolized.On (b)(6) 2022, bleeding was noted again.Endoscopic ultrasound (eus) guided coils and glue of the splenic varices were performed.The stent remains implanted and the physician is comfortable leaving the stent in place.The patient is being evaluated and will be going into surgery.In the physician's assessment the axios stent is related to the patient complications as the splenic varix errored into axios stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key13591269
MDR Text Key286057412
Report Number3005099803-2022-00902
Device Sequence Number1
Product Code PCU
UDI-Device Identifier08714729904588
UDI-Public08714729904588
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K153088
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00553640
Device Catalogue Number5364
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/01/2022
Initial Date FDA Received02/24/2022
Supplement Dates Manufacturer Received03/01/2022
Supplement Dates FDA Received03/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age55 YR
Patient SexMale
Patient Weight76 KG
Patient RaceWhite
-
-